Table 1.

Cases of Gordonia bacteremia from 1999 to 2013 at the Mayo Clinic, Rochester, MN

No.	Age (yr)	Gender	Species	Underlying comorbidity(ies)a	Presence of indwelling CVCb	Type of infection	Treatment and duration	Clinical outcome	Yr of isolation
1	38	Male	G. otiditis	AML s/p-MUD allogeneic PBSCT	Hickman catheter	Line-associated bacteremia	Vancomycin for 7 days	Resolution of infection	2013
2	48	Male	G. polyisoprenivorans	AML s/p-MUD allogeneic PBSCT	Hickman catheter	Line-associated bacteremia	Vancomycin and cefepime prior to identification, followed by ceftriaxone for 4 weeks	Resolution of infection	2012
3	81	Female	G. terrae	ESRD, HD, DM, PAD	Tunneled dialysis catheter	Bacteremia; possible contaminant	Vancomycin and cefepime for 3 daysc	Resolution of symptoms	2011
4	67	Female	G. bronchialis	DM, autoimmune thyroiditis, concurrent HSV encephalitis	None	Bacteremia	Multiple antibioticsd for a total of 10 days	Resolution of infection	2010
5	4	Female	Gordonia sp., not further identified	ALL with CNS relapse, concurrent Tsukamurella bacteremia	Hickman catheter	Line-associated bacteremia	TMP-SMX for 2 weeks, followed by clarithromycin for 4 weeks	Resolution of infection	1999

^aAbbreviations: ALL, acute lymphoblastic leukemia; CNS, central nervous system; HSV, herpes simplex virus; DM, diabetes mellitus; ESRD, end-stage renal disease; HD, hemodialysis; PAD, peripheral arterial disease; MUD, matched unrelated donor; PBSCT, peripheral blood stem cell transplant; s/p, status post.

^bCVC, central venous catheter.

^cThe organism was considered to be a contaminant and not clinically significant.

^dVancomycin, cefepime, piperacillin-tazobactam, and cefazolin.